Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Metformin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Myeloid 1 Sarcoma, Ewing 1 Sarcoma 1 Osteosarcoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Gliosarcoma 1 Glioblastoma 1 Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cyclophosphamide 21 Temozolomide 19 Irinotecan 16 Vincristine 14 Doxorubicin 11 Topotecan 10 Melphalan 10 Etoposide 9 Busulfan 8 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Magnetic Resonance Spectroscopy 6 Filgrastim 6 cabozantinib 5 X-Rays 5 Sirolimus 5 Drug Therapy 5 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 fludarabine phosphate 4 fludarabine 4 Trabectedin 4 Specimen Handling 4 Phantoms, Imaging 4 Gemcitabine 4 regorafenib 3 irinotecan sucrosofate 3 ganitumab 3 abemaciclib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04758000 2023-08-04

Metform-Bone

Istituto Ortopedico Rizzoli

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡